市場調査レポート

商品コード

ECMO（体外式膜型人工肺）の世界市場 2023-2027

Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027

出版日: 2022年12月23日 | 発行: TechNavio

| ページ情報: 英文 167 Pages | 納期: 即納可能

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 2,500 391,900円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 627,040円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートではECMO（体外式膜型人工肺）の市場規模は、2022年から2027年の間に2億4360万米ドルの増加が見込まれ、予測期間中にCAGR10.05％で成長すると予測しています。

当レポートでは、ECMO（体外式膜型人工肺）市場の全体分析、市場規模と予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析などをお届けします。

現在の市場動向と促進要因、市場環境全体に関する最新の分析を提供しています。市場は、呼吸不全や心不全の発生率の増加、新製品の上市数の増加、移植手術の増加などによって牽引されています。

本調査では、技術の進歩が今後数年間のECMO（体外式膜型人工肺）市場の成長を促進する主要な理由の1つであると特定しています。また、呼吸不全の疾患や乳幼児の治療における良好な結果が、市場の大きな需要につながると考えられます。

地域別セグメンテーション
地域別比較
北米 - 市場規模と予測 2022-2027
欧州 - 市場規模と予測 2022-2027
アジア - 市場規模と予測 2022-2027
その他の地域（ROW） - 市場規模と予測 2022-2027
米国 - 市場規模と予測 2022-2027
ドイツ - 市場規模と予測 2022-2027
カナダ - 市場規模と予測 2022-2027
英国 - 市場規模と予測 2022-2027
中国 - 市場規模と予測 2022-2027
地域情勢別の市場機会

第10章促進要因、課題、および動向

市場促進要因
市場の課題
促進要因と課題の影響
市場動向

第11章ベンダー情勢

概要
ベンダー情勢
混乱の状況
業界のリスク

第12章ベンダー分析

対象ベンダー
ベンダーの市場ポジショニング
Abbott Laboratories
Braile Biomedica
Chalice Medical Ltd.
Eurosets Srl
Fresenius Medical Care AG and Co. KGaA
Getinge AB
LivaNova Plc
MC3 Cardiopulmonary
Medtronic Plc
MicroPort Scientific Corp.
Nipro Corp.
OriGen Biomedical Inc.
Sechrist Industries Inc.
Terumo Corp.
Xenios AG

第13章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Modality
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global extracorporeal membrane oxygenation machines market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Modality Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Modality - Market share 2022-2027 (%)
Exhibits31: Data Table on Modality - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Modality
Exhibits33: Data Table on Comparison by Modality
Exhibits34: Chart on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Veno-arterial - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Veno-arterial - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Veno-arterial - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Veno-arterial - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Modality ($ million)
Exhibits43: Chart on Product - Market share 2022-2027 (%)
Exhibits44: Data Table on Product - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product
Exhibits46: Data Table on Comparison by Product
Exhibits47: Chart on ECMO machines - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on ECMO machines - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on ECMO machines - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on ECMO machines - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Softwares - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Softwares - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Softwares - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Softwares - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Abbott Laboratories - Overview
Exhibits105: Abbott Laboratories - Business segments
Exhibits106: Abbott Laboratories - Key news
Exhibits107: Abbott Laboratories - Key offerings
Exhibits108: Abbott Laboratories - Segment focus
Exhibits109: Braile Biomedica - Overview
Exhibits110: Braile Biomedica - Product / Service
Exhibits111: Braile Biomedica - Key offerings
Exhibits112: Chalice Medical Ltd. - Overview
Exhibits113: Chalice Medical Ltd. - Product / Service
Exhibits114: Chalice Medical Ltd. - Key offerings
Exhibits115: Eurosets Srl - Overview
Exhibits116: Eurosets Srl - Product / Service
Exhibits117: Eurosets Srl - Key offerings
Exhibits118: Fresenius Medical Care AG and Co. KGaA - Overview
Exhibits119: Fresenius Medical Care AG and Co. KGaA - Business segments
Exhibits120: Fresenius Medical Care AG and Co. KGaA - Key news
Exhibits121: Fresenius Medical Care AG and Co. KGaA - Key offerings
Exhibits122: Fresenius Medical Care AG and Co. KGaA - Segment focus
Exhibits123: Getinge AB - Overview
Exhibits124: Getinge AB - Business segments
Exhibits125: Getinge AB - Key news
Exhibits126: Getinge AB - Key offerings
Exhibits127: Getinge AB - Segment focus
Exhibits128: LivaNova Plc - Overview
Exhibits129: LivaNova Plc - Business segments
Exhibits130: LivaNova Plc - Key offerings
Exhibits131: LivaNova Plc - Segment focus
Exhibits132: MC3 Cardiopulmonary - Overview
Exhibits133: MC3 Cardiopulmonary - Product / Service
Exhibits134: MC3 Cardiopulmonary - Key offerings
Exhibits135: Medtronic Plc - Overview
Exhibits136: Medtronic Plc - Business segments
Exhibits137: Medtronic Plc - Key news
Exhibits138: Medtronic Plc - Key offerings
Exhibits139: Medtronic Plc - Segment focus
Exhibits140: MicroPort Scientific Corp. - Overview
Exhibits141: MicroPort Scientific Corp. - Business segments
Exhibits142: MicroPort Scientific Corp. - Key offerings
Exhibits143: MicroPort Scientific Corp. - Segment focus
Exhibits144: Nipro Corp. - Overview
Exhibits145: Nipro Corp. - Business segments
Exhibits146: Nipro Corp. - Key offerings
Exhibits147: Nipro Corp. - Segment focus
Exhibits148: OriGen Biomedical Inc. - Overview
Exhibits149: OriGen Biomedical Inc. - Product / Service
Exhibits150: OriGen Biomedical Inc. - Key offerings
Exhibits151: Sechrist Industries Inc. - Overview
Exhibits152: Sechrist Industries Inc. - Product / Service
Exhibits153: Sechrist Industries Inc. - Key offerings
Exhibits154: Terumo Corp. - Overview
Exhibits155: Terumo Corp. - Business segments
Exhibits156: Terumo Corp. - Key news
Exhibits157: Terumo Corp. - Key offerings
Exhibits158: Terumo Corp. - Segment focus
Exhibits159: Xenios AG - Overview
Exhibits160: Xenios AG - Product / Service
Exhibits161: Xenios AG - Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations

Product Code: IRTNTR40185

Technavio has been monitoring the extracorporeal membrane oxygenation machines market and is forecast to grow by $243.6 million during 2022-2027, accelerating at a CAGR of 10.05% during the forecast period. Our report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of respiratory and heart failure, the rising number of new product launches, and the growing number of transplant procedures.

Technavio's extracorporeal membrane oxygenation machines market is segmented as below:

By Modality

Veno-venous
Arterio-venous
Veno-arterial

By Product

ECMO machines
Softwares

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies technological advances as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, positive results in respiratory failure diseases and treatment in infants will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the extracorporeal membrane oxygenation machines market covers the following areas:

Extracorporeal membrane oxygenation machines market sizing
Extracorporeal membrane oxygenation machines market forecast
Extracorporeal membrane oxygenation machines market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Modality
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global extracorporeal membrane oxygenation machines market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global extracorporeal membrane oxygenation machines market 2017 - 2021 ($ million)
4.2 Modality Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Modality Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Modality

6.1 Market segments
Exhibit 30: Chart on Modality - Market share 2022-2027 (%)
Exhibit 31: Data Table on Modality - Market share 2022-2027 (%)
6.2 Comparison by Modality
Exhibit 32: Chart on Comparison by Modality
Exhibit 33: Data Table on Comparison by Modality
6.3 Veno-venous and arterio-venous - Market size and forecast 2022-2027
Exhibit 34: Chart on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
6.4 Veno-arterial - Market size and forecast 2022-2027
Exhibit 38: Chart on Veno-arterial - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Veno-arterial - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Veno-arterial - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Veno-arterial - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Modality
Exhibit 42: Market opportunity by Modality ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 43: Chart on Product - Market share 2022-2027 (%)
Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 45: Chart on Comparison by Product
Exhibit 46: Data Table on Comparison by Product
7.3 ECMO machines - Market size and forecast 2022-2027
Exhibit 47: Chart on ECMO machines - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on ECMO machines - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on ECMO machines - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on ECMO machines - Year-over-year growth 2022-2027 (%)
7.4 Softwares - Market size and forecast 2022-2027
Exhibit 51: Chart on Softwares - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Softwares - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Softwares - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Softwares - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 55: Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 85: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 104: Abbott Laboratories - Overview
Exhibit 105: Abbott Laboratories - Business segments
Exhibit 106: Abbott Laboratories - Key news
Exhibit 107: Abbott Laboratories - Key offerings
Exhibit 108: Abbott Laboratories - Segment focus
12.4 Braile Biomedica
Exhibit 109: Braile Biomedica - Overview
Exhibit 110: Braile Biomedica - Product / Service
Exhibit 111: Braile Biomedica - Key offerings
12.5 Chalice Medical Ltd.
Exhibit 112: Chalice Medical Ltd. - Overview
Exhibit 113: Chalice Medical Ltd. - Product / Service
Exhibit 114: Chalice Medical Ltd. - Key offerings
12.6 Eurosets Srl
Exhibit 115: Eurosets Srl - Overview
Exhibit 116: Eurosets Srl - Product / Service
Exhibit 117: Eurosets Srl - Key offerings
12.7 Fresenius Medical Care AG and Co. KGaA
Exhibit 118: Fresenius Medical Care AG and Co. KGaA - Overview
Exhibit 119: Fresenius Medical Care AG and Co. KGaA - Business segments
Exhibit 120: Fresenius Medical Care AG and Co. KGaA - Key news
Exhibit 121: Fresenius Medical Care AG and Co. KGaA - Key offerings
Exhibit 122: Fresenius Medical Care AG and Co. KGaA - Segment focus
12.8 Getinge AB
Exhibit 123: Getinge AB - Overview
Exhibit 124: Getinge AB - Business segments
Exhibit 125: Getinge AB - Key news
Exhibit 126: Getinge AB - Key offerings
Exhibit 127: Getinge AB - Segment focus
12.9 LivaNova Plc
Exhibit 128: LivaNova Plc - Overview
Exhibit 129: LivaNova Plc - Business segments
Exhibit 130: LivaNova Plc - Key offerings
Exhibit 131: LivaNova Plc - Segment focus
12.10 MC3 Cardiopulmonary
Exhibit 132: MC3 Cardiopulmonary - Overview
Exhibit 133: MC3 Cardiopulmonary - Product / Service
Exhibit 134: MC3 Cardiopulmonary - Key offerings
12.11 Medtronic Plc
Exhibit 135: Medtronic Plc - Overview
Exhibit 136: Medtronic Plc - Business segments
Exhibit 137: Medtronic Plc - Key news
Exhibit 138: Medtronic Plc - Key offerings
Exhibit 139: Medtronic Plc - Segment focus
12.12 MicroPort Scientific Corp.
Exhibit 140: MicroPort Scientific Corp. - Overview
Exhibit 141: MicroPort Scientific Corp. - Business segments
Exhibit 142: MicroPort Scientific Corp. - Key offerings
Exhibit 143: MicroPort Scientific Corp. - Segment focus
12.13 Nipro Corp.
Exhibit 144: Nipro Corp. - Overview
Exhibit 145: Nipro Corp. - Business segments
Exhibit 146: Nipro Corp. - Key offerings
Exhibit 147: Nipro Corp. - Segment focus
12.14 OriGen Biomedical Inc.
Exhibit 148: OriGen Biomedical Inc. - Overview
Exhibit 149: OriGen Biomedical Inc. - Product / Service
Exhibit 150: OriGen Biomedical Inc. - Key offerings
12.15 Sechrist Industries Inc.
Exhibit 151: Sechrist Industries Inc. - Overview
Exhibit 152: Sechrist Industries Inc. - Product / Service
Exhibit 153: Sechrist Industries Inc. - Key offerings
12.16 Terumo Corp.
Exhibit 154: Terumo Corp. - Overview
Exhibit 155: Terumo Corp. - Business segments
Exhibit 156: Terumo Corp. - Key news
Exhibit 157: Terumo Corp. - Key offerings
Exhibit 158: Terumo Corp. - Segment focus
12.17 Xenios AG
Exhibit 159: Xenios AG - Overview
Exhibit 160: Xenios AG - Product / Service
Exhibit 161: Xenios AG - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 162: Inclusions checklist
Exhibit 163: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 164: Currency conversion rates for US$
13.4 Research methodology
Exhibit 165: Research methodology
Exhibit 166: Validation techniques employed for market sizing
Exhibit 167: Information sources
13.5 List of abbreviations
Exhibit 168: List of abbreviations

ECMO（体外式膜型人工肺）の世界市場 2023-2027

Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模

第4章市場規模実績

第5章ファイブフォース分析

第6章モダリティ別市場セグメンテーション

第7章製品別の市場セグメンテーション

第8章顧客情勢

第9章地域別情勢

第10章促進要因、課題、および動向

第11章ベンダー情勢

第12章ベンダー分析

第13章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Modality

7 Market Segmentation by Product

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

ECMO（体外式膜型人工肺）の世界市場 2023-2027

Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 モダリティ別市場セグメンテーション

第7章 製品別の市場セグメンテーション

第8章 顧客情勢

第9章 地域別情勢

第10章 促進要因、課題、および動向

第11章 ベンダー情勢

第12章 ベンダー分析

第13章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Modality

7 Market Segmentation by Product

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模

第4章市場規模実績

第5章ファイブフォース分析

第6章モダリティ別市場セグメンテーション

第7章製品別の市場セグメンテーション

第8章顧客情勢

第9章地域別情勢

第10章促進要因、課題、および動向

第11章ベンダー情勢

第12章ベンダー分析

第13章付録